| |
Online pharmacy of generic drugs for pain relief
The main group of painkillers are different in chemical structure and mechanism of action of medicinal substances. Among the main drugs of pain are analgesics. Distinguish non-narcotic and narcotic analgesics. For non-narcotic analgesics include various synthetic drugs (analginum, acetylsalicylic acid, butadion, paracetamol, etc.). Compared with the narcotic analgesics, they have less assuager activity and are effective mainly for pain arising from inflammatory lesions in various organs and tissues.
|
|
 |
Pharmacy news
04.11.2009
Book Correction Notice for `Handbook on Injectable Drugs, 15th Edition`
BETHESDA, MD 05 November 2009—There is an error in the monograph for Remifentanil Hydrochloride in Handbook on Injectable Drugs, 15th Edition, published by ASHP and edited... |
|
02.08.2009
Book Correction Notice for `Pediatric Injectable Drugs, Eighth Edition`
BETHESDA, MD 03 August 2009—There is an important correction to the monograph for Diltiazem HCl in Pediatric Injectable Drugs, Eighth Edition (the Teddy Bear Book),... |
|
07.07.2010
Book Correction Notice for `Pediatric Injectable Drugs, Ninth Edition`
BETHESDA, MD 07 July 2010—There is an important correction to the monograph for Piperacillin Sodium–Tazobactam Sodium in Pediatric Injectable Drugs, Ninth Edition (the... |
|
28.10.2010
Book Correction Notice for `Pediatric Injectable Drugs, Ninth Edition`
BETHESDA, MD 28 October 2010—There are three new, important corrections to monographs in Pediatric Injectable Drugs, Ninth Edition (The Teddy Bear Book), published by ASHP. ... |
|
16.08.2011
Book Correction Notice for `Pediatric Injectable Drugs, Ninth Edition`
BETHESDA, MD 16 August 2011—There is an important correction to the Milrinone Lactate monograph in Pediatric Injectable Drugs, Ninth Edition ("The Teddy Bear Book"),... |
|
29.04.2009
Botulinum Toxin Products Get Boxed Warning, Medication Guide
BETHESDA, MD 30 April 2009—FDA announced today that the makers of botulinum toxin products must add a boxed warning to their labeling about the risk of neurologic effects... |
|
03.05.2011
Bristol-Myers Squibb Recalls Coumadin 5-mg Tablets, Lot 9H49374A
BETHESDA, MD 03 May 2011—Bristol-Myers Squibb Company on May 2 announced a recall (PDF) of Coumadin 5-mg tablets in lot 9H49374A because a company-conducted test of a tablet... |
|
28.01.2011
CDC Revises Meningitis Vaccine Recommendations, General Vaccination Advice
BETHESDA, MD 28 January 2011—The Centers for Disease Control and Prevention (CDC) this week released its official recommendations for the use of quadrivalent meningococcal... |
|
07.09.2009
CDC Urges Judicious Use of Antiinfluenza Drugs
BETHESDA, MD 08 September 2009—An updated guidance document from the Centers for Disease Control and Prevention (CDC) asks health care professionals to treat influenza with... |
|
29.12.2010
Children`s Hospitals Gain Legislative Victory on 340B Orphan Drugs
BETHESDA, MD 29 December 2010—Children`s hospitals got an early holiday present from Capitol Hill—the passage of legislation that reinstates 340B discounts for orphan drug... |
|
|
 |
|
|
